APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor B

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vascular Endothelial Growth Factor B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174045250322 December 2025186 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor B Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor B Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor B Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor B Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Vascular Endothelial Growth Factor B market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vascular Endothelial Growth Factor B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vascular Endothelial Growth Factor B include Eli Lilly and Company, Regeneron Pharmaceuticals Inc, Formycon AG, CSL Ltd and Alteogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vascular Endothelial Growth Factor B market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vascular Endothelial Growth Factor B and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vascular Endothelial Growth Factor B sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vascular Endothelial Growth Factor B market size, projected growth trends, production technologies, key applications, and end-use industries.

Vascular Endothelial Growth Factor B Segment by Company

Eli Lilly and Company

Regeneron Pharmaceuticals Inc

Formycon AG

CSL Ltd

Alteogen Inc

Vascular Endothelial Growth Factor B Segment by Type

CSL-346

Aflibercept

Aflibercept Biosimilar

Others

Vascular Endothelial Growth Factor B Segment by Application

Rectal Cancer

Diabetic Nephropathy

Retinal Vein Occlusion

Others

Vascular Endothelial Growth Factor B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vascular Endothelial Growth Factor B market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vascular Endothelial Growth Factor B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vascular Endothelial Growth Factor B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vascular Endothelial Growth Factor B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vascular Endothelial Growth Factor B Industry Trends Table 2. Vascular Endothelial Growth Factor B Industry Drivers Table 3. Vascular Endothelial Growth Factor B Industry Opportunities and Challenges Table 4. Vascular Endothelial Growth Factor B Industry Restraints Table 5. Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vascular Endothelial Growth Factor B Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vascular Endothelial Growth Factor B Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers Table 9. Global Vascular Endothelial Growth Factor B Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Vascular Endothelial Growth Factor B Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vascular Endothelial Growth Factor B Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vascular Endothelial Growth Factor B Manufacturers, Product Type & Application Table 13. Global Vascular Endothelial Growth Factor B Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vascular Endothelial Growth Factor B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of CSL-346 Table 17. Major Manufacturers of Aflibercept Table 18. Major Manufacturers of Aflibercept Biosimilar Table 19. Major Manufacturers of Others Table 20. Global Vascular Endothelial Growth Factor B Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Vascular Endothelial Growth Factor B Sales by Type (2021-2026) & (k units) Table 22. Global Vascular Endothelial Growth Factor B Sales by Type (2027-2032) & (k units) Table 23. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2026) Table 24. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2027-2032) Table 25. Global Vascular Endothelial Growth Factor B Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Vascular Endothelial Growth Factor B Revenue by Type (2021-2026) & (k units) Table 27. Global Vascular Endothelial Growth Factor B Revenue by Type (2027-2032) & (k units) Table 28. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2026) Table 29. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Rectal Cancer Table 31. Major Manufacturers of Diabetic Nephropathy Table 32. Major Manufacturers of Retinal Vein Occlusion Table 33. Major Manufacturers of Others Table 34. Global Vascular Endothelial Growth Factor B Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Vascular Endothelial Growth Factor B Sales by Application (2021-2026) & (k units) Table 36. Global Vascular Endothelial Growth Factor B Sales by Application (2027-2032) & (k units) Table 37. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2026) Table 38. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2027-2032) Table 39. Global Vascular Endothelial Growth Factor B Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Vascular Endothelial Growth Factor B Revenue by Application (2021-2026) & (k units) Table 41. Global Vascular Endothelial Growth Factor B Revenue by Application (2027-2032) & (k units) Table 42. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2026) Table 43. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2027-2032) Table 44. Global Vascular Endothelial Growth Factor B Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026) & (k units) Table 46. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2021-2026) Table 47. Global Vascular Endothelial Growth Factor B Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Vascular Endothelial Growth Factor B Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 51. North America Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 52. Europe Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 54. Europe Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2027-2032) & (k units) Table 61. Global Vascular Endothelial Growth Factor B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Vascular Endothelial Growth Factor B Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Vascular Endothelial Growth Factor B Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2021-2026) Table 65. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2027-2032) Table 66. Eli Lilly and Company Company Information Table 67. Eli Lilly and Company Business Overview Table 68. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio Table 70. Eli Lilly and Company Recent Development Table 71. Regeneron Pharmaceuticals Inc Company Information Table 72. Regeneron Pharmaceuticals Inc Business Overview Table 73. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio Table 75. Regeneron Pharmaceuticals Inc Recent Development Table 76. Formycon AG Company Information Table 77. Formycon AG Business Overview Table 78. Formycon AG Vascular Endothelial Growth Factor B Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Formycon AG Vascular Endothelial Growth Factor B Product Portfolio Table 80. Formycon AG Recent Development Table 81. CSL Ltd Company Information Table 82. CSL Ltd Business Overview Table 83. CSL Ltd Vascular Endothelial Growth Factor B Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio Table 85. CSL Ltd Recent Development Table 86. Alteogen Inc Company Information Table 87. Alteogen Inc Business Overview Table 88. Alteogen Inc Vascular Endothelial Growth Factor B Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio Table 90. Alteogen Inc Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Vascular Endothelial Growth Factor B Distributors List Table 94. Vascular Endothelial Growth Factor B Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Vascular Endothelial Growth Factor B Product Image Figure 2. Global Vascular Endothelial Growth Factor B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vascular Endothelial Growth Factor B Market Size (2021-2032) & (US$ Million) Figure 4. Global Vascular Endothelial Growth Factor B Sales (2021-2032) & (k units) Figure 5. Global Vascular Endothelial Growth Factor B Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Vascular Endothelial Growth Factor B Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. CSL-346 Image Figure 9. Aflibercept Image Figure 10. Aflibercept Biosimilar Image Figure 11. Others Image Figure 12. Global Vascular Endothelial Growth Factor B Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Vascular Endothelial Growth Factor B Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2032) Figure 15. Global Vascular Endothelial Growth Factor B Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Vascular Endothelial Growth Factor B Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2032) Figure 18. Rectal Cancer Image Figure 19. Diabetic Nephropathy Image Figure 20. Retinal Vein Occlusion Image Figure 21. Others Image Figure 22. Global Vascular Endothelial Growth Factor B Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Vascular Endothelial Growth Factor B Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2032) Figure 25. Global Vascular Endothelial Growth Factor B Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Vascular Endothelial Growth Factor B Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2032) Figure 28. North America Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 30. U.S. Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 35. Germany Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 42. China Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2021-2032) Figure 50. Brazil Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Vascular Endothelial Growth Factor B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Figure 61. North America Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Figure 63. Europe Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Vascular Endothelial Growth Factor B Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Vascular Endothelial Growth Factor B Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Vascular Endothelial Growth Factor B Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CSL-346
  • Aflibercept
  • Aflibercept Biosimilar
  • Others
Applications
  • Rectal Cancer
  • Diabetic Nephropathy
  • Retinal Vein Occlusion
  • Others
Companies covered
  • Eli Lilly and Company
  • Regeneron Pharmaceuticals Inc
  • Formycon AG
  • CSL Ltd
  • Alteogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vascular Endothelial Growth Factor B Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vascular Endothelial Growth Factor B Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vascular Endothelial Growth Factor B Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vascular Endothelial Growth Factor B Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vascular Endothelial Growth Factor B Market Dynamics
  1. 2.1 Vascular Endothelial Growth Factor B Industry Trends
  2. 2.2 Vascular Endothelial Growth Factor B Industry Drivers
  3. 2.3 Vascular Endothelial Growth Factor B Industry Opportunities and Challenges
  4. 2.4 Vascular Endothelial Growth Factor B Industry Restraints
3 Vascular Endothelial Growth Factor B Market by Manufacturers
  1. 3.1 Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vascular Endothelial Growth Factor B Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vascular Endothelial Growth Factor B Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vascular Endothelial Growth Factor B Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vascular Endothelial Growth Factor B Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vascular Endothelial Growth Factor B Manufacturers, Product Type & Application
  7. 3.7 Global Vascular Endothelial Growth Factor B Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vascular Endothelial Growth Factor B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vascular Endothelial Growth Factor B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vascular Endothelial Growth Factor B Tier 1, Tier 2, and Tier 3
4 Vascular Endothelial Growth Factor B Market by Type
  1. 4.1 Vascular Endothelial Growth Factor B Type Introduction
  2. 4.1.1 CSL-346
  3. 4.1.2 Aflibercept
  4. 4.1.3 Aflibercept Biosimilar
  5. 4.1.4 Others
  6. 4.2 Global Vascular Endothelial Growth Factor B Sales by Type
  7. 4.2.1 Global Vascular Endothelial Growth Factor B Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vascular Endothelial Growth Factor B Sales by Type (2021-2032)
  9. 4.2.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2021-2032)
  10. 4.3 Global Vascular Endothelial Growth Factor B Revenue by Type
  11. 4.3.1 Global Vascular Endothelial Growth Factor B Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Vascular Endothelial Growth Factor B Revenue by Type (2021-2032)
  13. 4.3.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2021-2032)
5 Vascular Endothelial Growth Factor B Market by Application
  1. 5.1 Vascular Endothelial Growth Factor B Application Introduction
  2. 5.1.1 Rectal Cancer
  3. 5.1.2 Diabetic Nephropathy
  4. 5.1.3 Retinal Vein Occlusion
  5. 5.1.4 Others
  6. 5.2 Global Vascular Endothelial Growth Factor B Sales by Application
  7. 5.2.1 Global Vascular Endothelial Growth Factor B Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Vascular Endothelial Growth Factor B Sales by Application (2021-2032)
  9. 5.2.3 Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2021-2032)
  10. 5.3 Global Vascular Endothelial Growth Factor B Revenue by Application
  11. 5.3.1 Global Vascular Endothelial Growth Factor B Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Vascular Endothelial Growth Factor B Revenue by Application (2021-2032)
  13. 5.3.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2021-2032)
6 Global Vascular Endothelial Growth Factor B Sales by Region
  1. 6.1 Global Vascular Endothelial Growth Factor B Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vascular Endothelial Growth Factor B Sales by Region (2021-2032)
  3. 6.2.1 Global Vascular Endothelial Growth Factor B Sales by Region (2021-2026)
  4. 6.2.2 Global Vascular Endothelial Growth Factor B Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vascular Endothelial Growth Factor B Revenue by Region
  1. 7.1 Global Vascular Endothelial Growth Factor B Revenue by Region
  2. 7.1.1 Global Vascular Endothelial Growth Factor B Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vascular Endothelial Growth Factor B Revenue by Region (2021-2026)
  4. 7.1.3 Global Vascular Endothelial Growth Factor B Revenue by Region (2027-2032)
  5. 7.1.4 Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vascular Endothelial Growth Factor B Revenue (2021-2032)
  8. 7.2.2 North America Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vascular Endothelial Growth Factor B Revenue (2021-2032)
  11. 7.3.2 Europe Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vascular Endothelial Growth Factor B Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vascular Endothelial Growth Factor B Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vascular Endothelial Growth Factor B Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly and Company
  2. 8.1.1 Eli Lilly and Company Company Information
  3. 8.1.2 Eli Lilly and Company Business Overview
  4. 8.1.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Product Portfolio
  6. 8.1.5 Eli Lilly and Company Recent Developments
  7. 8.2 Regeneron Pharmaceuticals Inc
  8. 8.2.1 Regeneron Pharmaceuticals Inc Company Information
  9. 8.2.2 Regeneron Pharmaceuticals Inc Business Overview
  10. 8.2.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product Portfolio
  12. 8.2.5 Regeneron Pharmaceuticals Inc Recent Developments
  13. 8.3 Formycon AG
  14. 8.3.1 Formycon AG Company Information
  15. 8.3.2 Formycon AG Business Overview
  16. 8.3.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Formycon AG Vascular Endothelial Growth Factor B Product Portfolio
  18. 8.3.5 Formycon AG Recent Developments
  19. 8.4 CSL Ltd
  20. 8.4.1 CSL Ltd Company Information
  21. 8.4.2 CSL Ltd Business Overview
  22. 8.4.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CSL Ltd Vascular Endothelial Growth Factor B Product Portfolio
  24. 8.4.5 CSL Ltd Recent Developments
  25. 8.5 Alteogen Inc
  26. 8.5.1 Alteogen Inc Company Information
  27. 8.5.2 Alteogen Inc Business Overview
  28. 8.5.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Alteogen Inc Vascular Endothelial Growth Factor B Product Portfolio
  30. 8.5.5 Alteogen Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vascular Endothelial Growth Factor B Value Chain Analysis
  2. 9.1.1 Vascular Endothelial Growth Factor B Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vascular Endothelial Growth Factor B Production Mode & Process
  6. 9.2 Vascular Endothelial Growth Factor B Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vascular Endothelial Growth Factor B Distributors
  9. 9.2.3 Vascular Endothelial Growth Factor B Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst